Introduction The current study evaluated the use of platelet‐rich plasma (PRP), an
autologous blood product with supraphysiologic concentrations of growth factors, in the …

Background: With promising outcomes, platelet-rich plasma (PRP) has recently been
suggested as a treatment for olfactory dysfunction (OD). Methods: Clinical studies utilizing …

Background: Long COVID has brought numerous challenges to healthcare, with olfactory
dysfunction (OD) being a particularly distressing outcome for many patients. The persistent …

Objective To investigate the effectiveness of platelet‐rich plasma (PRP) injection into the
olfactory clefts of coronavirus disease 2019 (COVID‐19) patients with persistent olfactory …

Background COVID-19-related olfactory dysfunction is an emerging problem with a
significant impact on the quality of life of affected individuals. Different lines of treatment …

Purpose Chronic rhinosinusitis (CRS) is a prevalent chronic disease observed on a global
scale. The utilization of endoscopic sinus surgery (ESS) has gained significant recognition …

Introduction To comprehensively evaluate the reported clinical effectiveness of platelet‐rich
plasma (PRP) in patients with chronic sinusitis undergoing endoscopic sinus surgery (ESS) …

Background: The number of olfactory dysfunction cases resistant to the therapy increased
after the pandemic of COVID-19, so platelet rich plasma (PRP) maybe effective. Objective …

Background: Chronic rhinosinusitis (CRS) poses significant health challenges, requiring
comprehensive management strategies including endoscopic sinus surgery (ESS). Platelet …

Introduction: The current study evaluated the use of platelet-rich plasma (PRP), an
autologous blood product with supraphysiologic concentrations of growth factors, in the …